Fertility sparing treatment in cervical cancer management in pregnancy

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11120%2F21%3A43921485" target="_blank" >RIV/00216208:11120/21:43921485 - isvavai.cz</a>

Nalezeny alternativní kódy

RIV/00064173:_____/21:N0000106

Výsledek na webu

<a href="https://doi.org/10.1016/j.bpobgyn.2021.03.014" target="_blank" >https://doi.org/10.1016/j.bpobgyn.2021.03.014</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1016/j.bpobgyn.2021.03.014" target="_blank" >10.1016/j.bpobgyn.2021.03.014</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Fertility sparing treatment in cervical cancer management in pregnancy

Popis výsledku v původním jazyce

The article focuses on fertility-sparing management during pregnancy and obstetrical management after fertility-sparing surgery. Over the years, more women in developed countries tend to delay childbirth to a later age, which leads to cervical cancer more often diagnosed during pregnancy. The advances in our understanding of prognosis and treatment options in these patients have helped us to address avenues and to circumvent standard therapy and fetal demise, respecting maternal and fetal chances. Childbearing trends also lead to an increase in the number of patients considering fertility-sparing management when diagnosed with cervical cancer. Such management represents a challenge for obstetricians as prior cervical surgery is a known risk factor for various adverse events. These include decreased fertility, second trimester miscarriage, preterm labor, or preterm premature rupture of membranes. Watchful follow-up and various prophylactic measures are keys when striving for the best possible outcome.

Název v anglickém jazyce

Fertility sparing treatment in cervical cancer management in pregnancy

Popis výsledku anglicky

The article focuses on fertility-sparing management during pregnancy and obstetrical management after fertility-sparing surgery. Over the years, more women in developed countries tend to delay childbirth to a later age, which leads to cervical cancer more often diagnosed during pregnancy. The advances in our understanding of prognosis and treatment options in these patients have helped us to address avenues and to circumvent standard therapy and fetal demise, respecting maternal and fetal chances. Childbearing trends also lead to an increase in the number of patients considering fertility-sparing management when diagnosed with cervical cancer. Such management represents a challenge for obstetricians as prior cervical surgery is a known risk factor for various adverse events. These include decreased fertility, second trimester miscarriage, preterm labor, or preterm premature rupture of membranes. Watchful follow-up and various prophylactic measures are keys when striving for the best possible outcome.

Druh

J_imp - Článek v periodiku v databázi Web of Science

CEP obor

—

OECD FORD obor

30214 - Obstetrics and gynaecology

Projekt

<a href="/cs/project/NU20-09-00174" target="_blank" >NU20-09-00174: Význam genetického profilu ovariálního karcinomu v prevenci vzniku, rozvoje a suboptimální léčebné odpovědi onemocnění</a><br>

Návaznosti

I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Rok uplatnění

2021

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Best Practice &amp; Research: Clinical Obstetrics &amp; Gynaecology

ISSN

1521-6934

e-ISSN

—

Svazek periodika

75

Číslo periodika v rámci svazku

September

Stát vydavatele periodika

NL - Nizozemsko

Počet stran výsledku

12

Strana od-do

101-112

Kód UT WoS článku

000685249100010

EID výsledku v databázi Scopus

2-s2.0-85105701010